Log in to save to my catalogue

EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer

EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9179265

EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer

About this item

Full title

EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer

Publisher

Switzerland: MDPI AG

Journal title

Cancers, 2022-06, Vol.14 (11), p.2813

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

It is known that miRNA-378a-3p (miR-378) could be induced by eicosapentaenoic acid (EPA), an omega-3 fatty acid. Herein, we first demonstrated how miR-378 exerts anti-prostate cancer (PCa) actions by influencing multiple target genes, including KLK2, KLK4, KLK6, and KLK14, which are implicated in PCa development, cell proliferation, and cell surviv...

Alternative Titles

Full title

EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9179265

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9179265

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers14112813

How to access this item